Catalent News

Catalent Analyst Ratings

BenzingaJul 11 11:01 ET

RBC Capital Reiterates Sector Perform on Catalent, Maintains $63.5 Price Target

BenzingaJul 11 11:00 ET

Analysts Conflicted on These Healthcare Names: Lantheus (LNTH) and Catalent (CTLT)

TipRanksJul 11 06:42 ET

Catalent Analyst Ratings

BenzingaJun 28 11:44 ET

Barclays Adjusts Catalent Price Target to $63 From $47

MT NewswiresJun 27 07:20 ET

Catalent's Resilient Growth and Positive Outlook Reinforce Buy Rating

TipRanksMay 10 01:45 ET

RBC Capital Sticks to Their Hold Rating for Catalent (CTLT)

TipRanksMay 9 06:51 ET

Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target Is $48

MT NewswiresApr 12 10:37 ET

Analysts Offer Insights on Healthcare Companies: Catalent (CTLT), Vertex Pharmaceuticals (VRTX) and Alkermes (ALKS)

TipRanksApr 12 01:50 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Catalent (CTLT), Alvotech (ALVO) and Immunocore Holdings (IMCR)

TipRanksApr 5 03:55 ET

Catalent Analyst Ratings

BenzingaApr 4 10:27 ET

Analysts Offer Insights on Healthcare Companies: Arbutus Biopharma (ABUS), Twist Bioscience (TWST) and Catalent (CTLT)

TipRanksMar 5 01:25 ET

Catalent Analyst Ratings

BenzingaFeb 20 10:25 ET

Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS), Alnylam Pharma (ALNY) and Catalent (CTLT)

TipRanksFeb 20 07:31 ET

Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), BeiGene (BGNE) and Catalent (CTLT)

TipRanksFeb 12 08:20 ET

Catalent (CTLT) Gets a Hold From Barclays

TipRanksFeb 12 03:46 ET

Analyst Maintains Hold Rating Amid Catalent's Strategic Acquisition and Complex Valuation

TipRanksFeb 7 08:35 ET

Stephens & Co. Downgrades Catalent to Equal-Weight, Announces $63.5 Price Target

BenzingaFeb 6 05:53 ET

Catalent Analyst Ratings

BenzingaFeb 6 05:52 ET

Barclays Sticks to Their Hold Rating for Catalent (CTLT)

TipRanksFeb 6 01:25 ET